Statistics

Total Visits

Views
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients87

Select a period of time:

Number of views in the range

Views
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients28

Views

Views
November 20258
December 20252
January 20261
February 20260
March 20264
April 20269
May 20264
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Brazil5
Australia1
Switzerland1
Germany1
Dominican Republic1
Ecuador1
France1
Mexico1
Poland1
 

Top cities views

Views
San Jose4
Los Angeles3
Ashburn3
Belo Horizonte1
Dakar1
Dortmund1
Esmeraldas1
Johannesburg1
Manaus1
Marília1